(Q37801275)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20956994%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

title

Complementary medicine use by men with prostate cancer: a systematic review of prevalence studies (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20956994%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20956994%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

author name string

A Rea

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20956994%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

H Lewith

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20956994%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Y K Chan

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20956994%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

J Saville

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20956994%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

P Prescott

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20956994%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

E von Elm

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20956994%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

G T Lewith

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20956994%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

language of work or name

1 reference

19 October 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20956994%20AND%20SRC:MED&resulttype=core&format=json

Prostate Cancer and Prostatic Diseases

15 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20956994%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

volume

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20956994%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20956994%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

page(s)

1-13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20956994%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/pcan.2010.38

15 February 2020

exact match

0 references

cites work

Cancer statistics, 2009

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.38

Systematic review: comparative effectiveness and harms of treatments for clinically localized prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.38

Quality of life three years after diagnosis of localised prostate cancer: population based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.38

Prostate cancer and health-related quality of life: a review of the literature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.38

A detailed safety assessment of a saw palmetto extract

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.38

Herbal therapy PC-SPES: in vitro effects and evaluation of its efficacy in 69 patients with prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.38

PC-SPES: a herbal therapy for the treatment of hormone refractory prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.38

Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.38

Reasons for and characteristics associated with complementary and alternative medicine use among adult cancer patients: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.38

The prevalence of complementary/alternative medicine in cancer: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.38

Surveys of complementary and alternative medicine: Part II. Use of alternative and complementary cancer therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.38

Prevalence of complementary medicine use in pediatric cancer: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.38

The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.38

The Measurement of Observer Agreement for Categorical Data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.38

Use of complementary/alternative medicine by men diagnosed with prostate cancer: prevalence and characteristics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.38

Total and specific complementary and alternative medicine use in a large cohort of men with prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.38

Patterns of complementary and alternative medicine use among patients undergoing cancer treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.38

A population-based survey of complementary and alternative medicine use in men recently diagnosed with prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.38

A population-based study of prevalence of complementary methods use by cancer survivors: a report from the American Cancer Society's studies of cancer survivors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.38

The use and perceived benefit of complementary and alternative medicine among Californians with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.38

Motivations and influences on the use of complementary medicine in patients with localized prostate cancer treated with curative intent: results of a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.38

Use of complementary health practices by prostate carcinoma patients undergoing radiation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.38

Use of complementary and alternative medicine and prayer among a national sample of cancer survivors compared to other populations without cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.38

Ethnic differences in complementary and alternative medicine use among cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.38

Dietary supplement use in adult cancer survivors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.38

Use of complementary and alternative medicine in cancer patients: a European survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.38

Voodoo dolls and the cancer patient: patients do trust their doctors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.38

Types of alternative medicine used by patients with breast, colon, or prostate cancer: predictors, motives, and costs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.38

Changing patterns of CAM use among prostate cancer patients two years after diagnosis: reasons for maintenance or discontinuation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.38

Prayer and self-reported health among cancer survivors in the United States, National Health Interview Survey, 2002.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.38

Lifestyle correlates of health perception and treatment satisfaction in a clinical cohort of men with prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.38

Use of complementary and alternative medicine by cancer patients is not associated with perceived distress or poor compliance with standard treatment but with active coping behavior: a survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.38

A prospective study of the use of alternative therapies by men with localized prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.38

Patient initiation of complementary and alternative medical therapies (CAM) following cancer diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.38

The use of complementary therapy by men with prostate cancer in the UK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.38

Supplement use among men with prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.38

Complementary therapy use among older cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.38

Use of complementary and alternative medicine by patients with localized prostate carcinoma: study at a single institute in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.38

Use of complementary and alternative medicine by patients with urologic cancer: a prospective study at a single Japanese institution.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.38

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.38

Vitamins E and C in the prevention of prostate and total cancer in men: the Physicians' Health Study II randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.38

Nutraceuticals and prostate cancer prevention: a current review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.38

Associations between alpha-tocopherol, beta-carotene, and retinol and prostate cancer survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.38

Ingestion of selenium and other antioxidants during prostate cancer radiotherapy: a good thing?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.38

Development of an international questionnaire to measure use of complementary and alternative medicine (I-CAM-Q).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.38

Alternative therapies used by women with breast cancer in four ethnic populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.38

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.38

International trends and patterns of prostate cancer incidence and mortality

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.38

Serenoa repens for benign prostatic hyperplasia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.38

Clinical and biologic activity of an estrogenic herbal combination (PC-SPES) in prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.38

Clinical, demographic and psychosocial correlates of complementary and alternative medicine use by men diagnosed with localized prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.38

The use of complementary and alternative therapies by patients with cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.38

Use of complementary therapies among breast and prostate cancer patients during treatment: a multisite study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.38

Rates of unconventional medical therapy use in patients with prostate cancer: standard history versus directed questions

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.38

The use of complementary and alternative medical providers by insured cancer patients in Washington State

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.38

Complementary and alternative medicine use among men with prostate cancer in 4 ethnic populations

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.38

Cancer survivors with unmet needs were more likely to use complementary and alternative medicine

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.38

Determinants of the use of complementary therapies by patients with cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.38

Frequent use of complementary medicine by prostate cancer patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.38

Who Uses CAM? A Narrative Review of Demographic Characteristics and Health Factors Associated with CAM Use.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.38